Marksans Pharma Limited (NSE: MARKSANS)

Marksans Pharma Revenue

Marksans Pharma had revenue of 6.42B INR in the quarter ending September 30, 2024, with 20.84% growth. This brings the company's revenue in the last twelve months to 23.79B, up 19.11% year-over-year. In the fiscal year ending March 31, 2024, Marksans Pharma had annual revenue of 21.77B with 17.56% growth.

• Revenue (ttm): 23.79B
• Revenue Growth: +19.11%
• P/S Ratio: 5.60
• Revenue / Employee: 20.85M
• Employees: 1,141
• Market Cap: 133.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	21.77B	3.25B	17.56%
Mar 31, 2023	18.52B	3.61B	24.23%
Mar 31, 2022	14.91B	1.15B	8.33%
Mar 31, 2021	13.76B	2.42B	21.32%
Mar 31, 2020	11.34B	1.34B	13.43%